Aptissen SA

medical devices

About

Aptissen SA is a Swiss company founded in 2013, focused on the research, development, manufacturing, and commercialization of biopolymer-based medical devices and orthobiologic solutions for musculoskeletal health and joint disorders. Originating as a spin-off from Anteis SA, the company leverages over a decade of expertise in advanced polymers for tissue engineering. Aptissen's flagship product, Synolis™, is a patented injectable gel that combines Hyaluronic Acid and Sorbitol to alleviate pain associated with osteoarthritis. Additionally, the company offers Cartylis™, a drinkable food supplement that promotes collagen synthesis to enhance joint function. Their product portfolio also includes solutions for ophthalmology and orthopaedics, emphasizing patient benefits and quality of life improvements. Aptissen is ISO 13485:2016 certified and operates a global distribution network across over 50 countries, with subsidiaries in Italy, Poland, France, and Germany. The company actively seeks partnerships to expand its market reach and product offerings.

Technologies

Outlook Microsoft Office 365 Google Analytics Shutterstock Google Font API Hotjar Google Maps (Non Paid Users) Google Maps Mobile Friendly reCAPTCHA Shopify Google Tag Manager WordPress.org Typekit Apache Nginx AI Remote Hubspot

Keywords

osteoarthritis orthopaedic rheumatology joint pain viscosupplement hyaluronic acid injectable medical equipment manufacturing joint mobility enhancement medical equipment and supplies manufacturing synolis tm rehabilitation orthobiologic joint health supplement clinical data orthobiologics osteoarthritis treatment joint disorder treatment injectable viscosupplement sorbitol biotech life sciences patient care medical devices cartylis tm joint pain relief global distribution musculoskeletal solutions biologic solutions b2b

Location

36 Chemin du Champ-des-Filles, Plan-les-Ouates, Geneva, Switzerland, 1228

Related Companies

Companies in the same industry